Source: International Congress 2019 – Insights into physiological diagnostic services
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Stockley (Birmingham, United Kingdom), D. Crossley (Birmingham, United Kingdom), R. Stockley (Birmingham, United Kingdom), E. Sapey (Birmingham, United Kingdom). Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency. 3919

Member's Comments

No comment yet.

Related content which might interest you: COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Exercise in COPD Year: 2010 Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 The relationship of small airways disease to spirometry and emphysema in alpha-1 antitrypsin deficiency Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Ventilation inhomogeneity is correlated with biomarkers of parenchymal destruction in alpha1 antitrypsin deficiency Source: Eur Respir J 2007; 30: Suppl. 51, 620s Year: 2007 Immune activation in α1 antitrypsin deficiency (AATD) emphysema: Beyond the protease/antiprotease hypothesis Source: Annual Congress 2012 - Mechanistic studies in airway cell biology Year: 2012 Relationship between atopy, asthma and alpha-1 antitrypsin deficiency Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease. Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Change in lung function and CT lung density in alpha1 antitrypsin deficiency patients under augmentation therapy Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Alveolar nitric oxide correlates with lung volumes in patients with emphysema and Alpha-1 antitrypsin deficiency (AATD) Source: Eur Respir J 2006; 28: Suppl. 50, 223s Year: 2006 Clinical features of alpha one antitrypsin deficiency in COPD Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Substitution therapy in Alpha-1 antitrypsin deficiency after lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 724s Year: 2006 Lung function decline in relation to alpha-1-antitrypsin phenotypes in severe asthma Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003 Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005 Endobronchial valve treatment in patients with severe emphysema due to alpha-1 antitrypsin deficiency. Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease Year: 2019 Monitoring disease progression in severe Alpha1 antitrypsin deficiency Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020